SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.83-0.7%Dec 26 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (26718)12/1/1998 7:55:00 PM
From: Cheryl Galt  Read Replies (1) of 32384
 
Henry,

Thanks for reporting on this morning's conference call. I appreciate all your details.

Hopefully, Panretin gel will provide substantial and fairly non-toxic relief for many different kinds of lesions.

Hopefully, Ligand will have its first marketable drug in time for Christmas
-- a cause for a well-deserved celebration.

Cheryl
-----------

PS

I'm feeling sad at the loss of Seattle's Public Schools Superintendent John Stanford.
He died of acute myelogenous leukemia early Saturday morning, having battled it since April. In that time, while continuing to work, he went through three rounds of chemo, then a stem cell transplant, then started yet another round chemo after the cancer again recurred.

Too bad one of Ligand's less toxic molecules wasn't available to help him.
John Stanford was too good to lose.
seattletimes.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext